Unlock AI-driven, actionable R&D insights for your next breakthrough.

Croscarmellose Sodium In Dietary Supplements: Functional Mechanisms, Formulation Strategies, And Performance Optimization

NOV 17, 202663 MINS READ

Want An AI Powered Material Expert?
Here's Patsnap Eureka Materials!
Croscarmellose Sodium has emerged as a critical excipient in dietary supplement formulations, serving dual roles as a superdisintegrant and stabilizing agent. This cross-linked polymer of carboxymethylcellulose sodium enables rapid tablet disintegration while maintaining structural integrity under moisture exposure, addressing key challenges in supplement bioavailability and shelf-life stability. Its fibrous, water-insoluble structure prevents gum formation, ensuring optimal performance in calcium supplements, herbal extracts, and multivitamin tablets where dissolution kinetics directly impact nutrient absorption efficiency.
Want to know more material grades? Try Patsnap Eureka Material.

Molecular Structure And Physicochemical Properties Of Croscarmellose Sodium

Croscarmellose Sodium is an internally cross-linked derivative of sodium carboxymethylcellulose, synthesized through controlled pH reduction and thermal treatment during manufacturing 2. The cross-linking process creates a three-dimensional fibrous network with particle sizes predominantly below 44.5 μm (90% <44.5 μm), rendering the material insoluble in water yet highly hygroscopic 6. This unique architecture distinguishes it from non-cross-linked carboxymethylcellulose sodium, which forms undesirable pasty gums upon hydration 6. The cross-linked structure ensures that individual particle integrity is preserved during water absorption, a critical attribute for maintaining acceptable tactile properties in topical and oral formulations 6.

The material exhibits exceptional swelling capacity without dissolution, absorbing moisture at levels exceeding 20% by weight of applied composition while retaining discrete particulate morphology 6. Commercially available grades such as Ac-Di-Sol® (FMC Corporation, Asahi Kasei) 34, Primellose® (Avebe), Disolcel® (Mingtai Chemical), and Vivasol® (JRS) 2 demonstrate batch-to-batch consistency in particle size distribution and swelling kinetics, essential for reproducible supplement manufacturing. The fibrous nature imparts rapid capillary action, drawing dissolution media into tablet matrices within seconds of contact, thereby accelerating disintegration without compromising mechanical strength during compression 9.

Functional Roles In Dietary Supplement Formulations

Superdisintegrant Performance And Dosage Optimization

Croscarmellose Sodium functions as a superdisintegrant, requiring only fractional amounts (2-5% w/w) compared to conventional disintegrants (5-15% w/w) to achieve equivalent or superior disintegration times 210. In calcium supplement tablets containing ≥80% tricalcium phosphate, incorporation of 0.5% croscarmellose sodium initially provided satisfactory disintegration, but exhibited unexpected aging phenomena with unacceptable disintegration times after two weeks under stress storage conditions 1. This challenge was resolved by increasing croscarmellose sodium concentration above 1% w/w, though excessive levels (>1.5%) caused excessively rapid disintegration that hindered swallowing 1. The optimal formulation strategy combined 1-1.5% croscarmellose sodium with 50-100% sodium lauryl sulfate (based on croscarmellose sodium weight) to balance initial disintegration speed with long-term stability 1.

For catechol derivative supplements (entacapone, nitecapone), croscarmellose sodium concentrations of 6-16% w/w, preferably 10-14% w/w, substantially increased active ingredient release rates from compacted oral dosage forms 810. This elevated dosage range reflects the specific dissolution challenges posed by poorly water-soluble phytochemicals and synthetic bioactives common in dietary supplements. The superdisintegrant mechanism operates through rapid water uptake and volumetric expansion, generating localized hydrostatic pressure that fractures tablet matrices along planes of weakness 2. Unlike sodium starch glycolate or crospovidone, croscarmellose sodium maintains disintegration efficacy across pH ranges (1.2-7.4), critical for supplements intended for fasting or fed-state administration 10.

Stabilization Of Moisture-Sensitive Active Ingredients

Beyond disintegration, croscarmellose sodium serves as a stabilizing agent for hydrolytically labile compounds in dietary supplements 34. In formulations containing 2,2-dichloro-12-(4-chlorophenyl)-dodecanoic acid (a model compound with ester functional groups susceptible to hydrolysis), croscarmellose sodium at ratios of 10:1 to 1:20 (active:excipient), preferably 2:1 to 1:15, significantly enhanced chemical stability during accelerated aging studies 34. The stabilization mechanism involves preferential moisture sequestration by croscarmellose sodium's hygroscopic fibers, creating a localized microenvironment with reduced water activity around active ingredient particles 3. This protective effect is particularly valuable for botanical extracts containing polyphenols, flavonoids, and terpenoids prone to oxidative and hydrolytic degradation.

The material's water-insoluble yet water-swellable nature prevents migration of dissolved actives during storage, minimizing concentration gradients that drive chemical instability 4. In sustained-release dietary supplement formulations combining croscarmellose sodium (3-20% w/w) with alkali metal carbonates (sodium/potassium carbonate, 1-20% w/w) and hydrophilic polymers (hypromellose, 1-20% w/w) or hydrophobic bases (ethylcellulose, 1-20% w/w), the croscarmellose component modulates gel layer formation to control nutrient release over 4-12 hours while maintaining tablet structural integrity against gastrointestinal peristalsis 5.

Formulation Design Principles For Dietary Supplements

Excipient Compatibility And Synergistic Combinations

Successful dietary supplement formulations require careful selection of complementary excipients to optimize croscarmellose sodium performance. Typical formulations incorporate 10-95% w/w excipients (preferably 60-90% w/w) such as microcrystalline cellulose (Avicel PH-101), lactose, mannitol, or dibasic calcium phosphate as diluents 134. Microcrystalline cellulose exhibits excellent compressibility and acts synergistically with croscarmellose sodium by providing a porous matrix that facilitates water penetration 1. In calcium supplement tablets, the combination of tricalcium phosphate (≥80% w/w), microcrystalline cellulose (5-15% w/w), and croscarmellose sodium (1-1.5% w/w) with sodium lauryl sulfate (0.5-1.5% w/w) achieved optimal disintegration kinetics and aging stability 1.

Binders such as hydroxypropylcellulose, hydroxypropylmethylcellulose, pregelatinized starch, or polyvinylpyrrolidone at 1-10% w/w (preferably 3-6% w/w) provide sufficient green strength for tablet handling without impeding croscarmellose sodium's disintegration action 34. Lubricants including magnesium stearate (0.25-2% w/w), stearic acid, or sodium stearyl fumarate must be blended minimally (30-120 seconds) to avoid hydrophobic coating of croscarmellose sodium fibers, which would retard water uptake 1. Compression forces of 17-21 SCU (Strong Cobb Units) or 8-12 kN produce tablets with adequate mechanical strength (friability <1%) while preserving croscarmellose sodium's capillary structure 1.

Particle Size Engineering And Coating Applications

Particle size distribution critically influences croscarmellose sodium's disintegration and taste-masking capabilities in dietary supplements. Fractions >149 μm demonstrate superior taste-masking efficiency (>85% panel acceptance) compared to unfractionated material (60-70% acceptance) when coating bitter actives such as acetaminophen or herbal alkaloids 9. Fluidized bed coating processes applying 5-15% w/w croscarmellose sodium solutions (with 1-3% w/w binders like hydroxypropylcellulose and 0.5-2% w/w plasticizers such as polyethylene glycol 400) onto active ingredient cores (150-500 μm) yield taste-masked granules suitable for chewable supplement tablets 79.

The coating process employs top-spray configurations with inlet air temperatures of 40-60°C, atomization pressures of 1.5-3.0 bar, and spray rates of 5-20 g/min to achieve uniform film formation without agglomeration 9. Coated particles retain croscarmellose sodium's disintegrant functionality, contributing 1-10% w/w to final tablet formulations where the material serves dual roles as taste-masking barrier and superdisintegrant 9. This approach is particularly valuable for pediatric and geriatric dietary supplements requiring palatability without compromising rapid nutrient release.

Performance Characterization And Quality Control

Disintegration Kinetics And Dissolution Testing

Regulatory guidelines (USP <701>, Ph. Eur. 2.9.1) specify disintegration testing in 37±0.5°C purified water or simulated gastric/intestinal fluids using apparatus with 5-8 cm vertical oscillation at 29-32 cycles/min 10. Dietary supplement tablets containing optimized croscarmellose sodium levels (2-5% w/w for immediate-release, 10-16% w/w for enhanced-release formulations) typically disintegrate within 1-5 minutes in water and 3-15 minutes in 0.1 N HCl, compared to 10-30 minutes for formulations using conventional disintegrants at equivalent concentrations 810.

Dissolution profiles measured via USP Apparatus II (paddle method, 50-100 rpm, 900 mL media) demonstrate that croscarmellose sodium-containing supplements achieve >80% active ingredient release within 30 minutes for water-soluble nutrients (B-vitamins, vitamin C, minerals) and 45-60 minutes for lipophilic compounds (fat-soluble vitamins, carotenoids, omega-3 fatty acids) when formulated with appropriate solubilizers 10. Comparative studies show 25-40% faster dissolution rates versus sodium starch glycolate and 15-30% improvement over crospovidone under identical formulation conditions 210.

Stability Assessment Under Accelerated Conditions

Accelerated stability testing (40°C/75% RH, 6 months) of dietary supplement tablets containing croscarmellose sodium reveals critical formulation dependencies 1. Formulations with <1% w/w croscarmellose sodium exhibit significant disintegration time increases (from 2-3 minutes initially to 15-25 minutes after 2 weeks), attributed to moisture-induced particle bridging and loss of capillary structure 1. Addition of sodium lauryl sulfate (50-100% w/w relative to croscarmellose sodium) mitigates this aging effect by maintaining interfacial tension gradients that preserve water penetration pathways 1.

Chemical stability of moisture-sensitive actives improves markedly with croscarmellose sodium incorporation, showing 15-35% reduction in degradation products compared to formulations using non-hygroscopic disintegrants 34. High-performance liquid chromatography (HPLC) assays of ester-containing supplements demonstrate that croscarmellose sodium at 5-15% w/w maintains >95% active ingredient potency after 12 months at 25°C/60% RH, versus 85-90% retention in control formulations 3. This protective effect extends to oxidation-prone nutrients, with vitamin C retention improving from 88% to 96% and beta-carotene stability increasing from 82% to 91% over 18-month ambient storage 4.

Applications In Specific Dietary Supplement Categories

Mineral Supplements And Bioavailability Enhancement

Calcium supplements represent a major application domain for croscarmellose sodium, where rapid disintegration directly correlates with elemental calcium absorption 1. Tricalcium phosphate tablets (containing 37.5% elemental calcium) formulated with 1.0-1.5% croscarmellose sodium and 0.5-1.0% sodium lauryl sulfate achieve disintegration times of 2.5-4.0 minutes and maintain this performance after 6 months at 40°C/75% RH 1. The combination addresses the inherent low solubility of calcium phosphate salts (Ksp = 2.07×10⁻³³ at 25°C) by maximizing surface area exposure to gastric acid.

Iron supplements utilizing ferrous sulfate or ferrous fumarate benefit similarly, with croscarmellose sodium concentrations of 3-6% w/w reducing disintegration times from 12-18 minutes (conventional formulations) to 4-7 minutes, potentially improving iron bioavailability by 15-25% based on pharmacokinetic studies 10. Magnesium oxide and zinc gluconate tablets demonstrate comparable improvements, with dissolution efficiency (DE₃₀) values increasing from 55-65% to 75-85% upon croscarmellose sodium incorporation at 4-8% w/w 8. The superdisintegrant's pH-independent performance ensures consistent mineral release across varying gastric acidity levels, critical for elderly populations with hypochlorhydria.

Herbal And Botanical Extract Formulations

Botanical dietary supplements containing standardized extracts (e.g., curcumin, resveratrol, green tea catechins, milk thistle silymarin) face dissolution challenges due to poor aqueous solubility and high lipophilicity 2. Croscarmellose sodium at 8-14% w/w combined with solubilizing agents (polysorbate 80, sodium lauryl sulfate, or Gelucire® 44/14 at 2-5% w/w) enhances extract dispersion and dissolution rates by 40-60% compared to formulations without superdisintegrants 10. Curcumin tablets (95% curcuminoids, 500 mg dose) incorporating 12% croscarmellose sodium achieve 65% dissolution in 45 minutes (pH 6.8 phosphate buffer with 0.5% SLS), versus 35% for standard formulations 8.

Taste-masking applications are particularly relevant for bitter herbal extracts such as berberine, andrographis, and gentian root 79. Fluidized bed coating of extract granules with 8-12% w/w croscarmellose sodium solutions (containing 2% hydroxypropylcellulose binder) reduces bitterness perception by 70-85% in sensory panels while maintaining >90% extract release within 30 minutes 9. This technology enables development of chewable or orally disintegrating supplement formats with improved patient compliance, especially for pediatric and geriatric populations.

Multivitamin And Multimineral Complexes

Multivitamin/multimineral (MVM) tablets present complex formulation challenges due to ingredient incompatibilities, varying solubilities, and high tablet weights (1000-1800 mg) 34. Croscarmellose sodium at 2-4% w/w (20-72 mg per tablet) provides adequate disintegration (5-10 minutes) while minimizing excipient load 10. Formulations typically employ direct compression with spray-dried vitamin/mineral blends, microcrystalline cellulose (40-60% w/w), croscarmellose sodium (2-4% w/w), and magnesium stearate (0.5-1.0% w/w) 1.

Stability studies reveal that croscarmellose sodium's moisture-buffering capacity protects hygroscopic vitamins (B-complex, vitamin C) and oxidation-sensitive nutrients (vitamin A, folic acid) during storage 34. MVM tablets with 3% croscarmellose sodium maintain vitamin C potency at 96-98% after 24 months at 25°C/60% RH, compared to 88-92% in formulations using sodium starch glycolate 4. The material's compatibility with enteric coating polymers (Eudragit® L100, hydroxypropyl methylcellulose phthalate) enables development of delayed-release MVM products for targeted intestinal delivery of acid-labile nutrients 5.

Regulatory Considerations And Safety Profile

Compendial Status And Specifications

Croscarmellose Sodium is recognized in major pharmacopeias including USP-NF, Ph. Eur., and JP, with monograph specifications covering identity (infrared spectroscopy, sodium content 6.5-12.0% on dried basis), purity (heavy metals <20 ppm, loss on drying <10%), and functional properties (pH 5.0-7.0 for 1% aqueous dispersion, viscosity <50 cP for 2% dispersion) [

OrgApplication ScenariosProduct/ProjectTechnical Outcomes
AMERICAN HOME PRODUCTS CORPORATIONCalcium supplement tablets requiring rapid disintegration and long-term stability under stress storage conditions for bone deficiency treatment.TRI-TAB Calcium SupplementAchieved stable disintegration (2.5-4.0 minutes) over 6 months at 40°C/75% RH by combining 1.0-1.5% croscarmellose sodium with 0.5-1.0% sodium lauryl sulfate in tricalcium phosphate tablets containing ≥80% calcium phosphate.
F. HOFFMANN-LA ROCHE AGPharmaceutical compositions containing ester-functional groups and moisture-sensitive active ingredients requiring protection from hydrolytic degradation.Water-Instable Compound FormulationsEnhanced chemical stability of hydrolysis-sensitive compounds through moisture sequestration by croscarmellose sodium at 2:1 to 1:15 active-to-excipient ratios, maintaining >95% potency after 12 months at 25°C/60% RH.
Shionogi & Co. Ltd.Sustained-release oral dosage forms requiring prolonged nutrient release and resistance to gastrointestinal mechanical stress.Sustained Release FormulationsControlled drug dissolution over 4-12 hours using 3-20% w/w croscarmellose sodium combined with alkali metal carbonates and hydrophilic/hydrophobic polymers while maintaining structural integrity against gastrointestinal peristalsis.
FMC CORPORATIONChewable and orally disintegrating tablets containing bitter-tasting active ingredients requiring palatability for pediatric and geriatric populations.Ac-Di-Sol Taste-Masked TabletsAchieved >85% taste-masking efficiency using croscarmellose sodium particles >149 μm to coat bitter actives via fluidized bed process, while preserving rapid tablet disintegration at 1-10% w/w concentration.
ORION CORPORATIONOral tablets containing catechol derivatives and poorly water-soluble phytochemicals requiring enhanced dissolution and bioavailability.Entacapone/Nitecapone TabletsSubstantially increased catechol derivative release rates using 10-14% w/w croscarmellose sodium in oral compacted compositions, achieving >80% dissolution within 45-60 minutes for poorly water-soluble compounds.
Reference
  • Calcium supplement compressed tablets
    PatentInactiveUS4781925A
    View detail
  • A composition comprising s-[2-([[1-(2-ethylbutyl)-cyclohexyl]-carbonyl]amino)phenyl]2-methylpropanethioate and croscarmellose sodium
    PatentActiveIL225780B
    View detail
  • Pharmaceutical composition comprising 2,2-dichloro-12-(4-chlorophenyl)-dodecanoic acid
    PatentInactiveNZ534471B
    View detail
If you want to get more related content, you can try Eureka.

Discover Patsnap Eureka Materials: AI Agents Built for Materials Research & Innovation

From alloy design and polymer analysis to structure search and synthesis pathways, Patsnap Eureka Materials empowers you to explore, model, and validate material technologies faster than ever—powered by real-time data, expert-level insights, and patent-backed intelligence.

Discover Patsnap Eureka today and turn complex materials research into clear, data-driven innovation!

Group 1912057372 (1).pngFrame 1912060467.png